Korean J Med.  2013 Apr;84(4):562-566.

A Case of Diffuse Alveolar Hemorrhage Following Abciximab Therapy

Affiliations
  • 1Department of Internal Medicine, Daegu Fatima Hospital, Daegu, Korea. tangul8845@hanmail.net

Abstract

Platelets play an important role in the development of acute coronary syndrome. Platelet-inhibiting drugs, such as glycoprotein IIb/IIIa inhibitors, can be beneficial when they are administered at the time of primary percutaneous coronary intervention for acute coronary syndrome. Although an increased risk for bleeding complications is well recognized, the risk associated with diffuse alveolar hemorrhage is much less reported. We report a case of diffuse alveolar hemorrhage after using abciximab.

Keyword

Acute coronary syndrome; Hemoptysis

MeSH Terms

Acute Coronary Syndrome
Antibodies, Monoclonal
Blood Platelets
Glycoproteins
Hemoptysis
Hemorrhage
Immunoglobulin Fab Fragments
Percutaneous Coronary Intervention
Antibodies, Monoclonal
Glycoproteins
Immunoglobulin Fab Fragments
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr